CHRISTIN ROWE: Open Payments
NPI 1730129479 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,135 in 140 payments from 22 companies in 2025. Trend: 2023 $3,215 · 2024 $4,129 · 2025 $3,135
Food & beverage: $3,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $525 |
| Incyte Corporation | 15 | $421 |
| Janssen Biotech, Inc. | 21 | $398 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 14 | $359 |
| Galderma Laboratories, L.P. | 10 | $264 |
| UCB, Inc. | 9 | $191 |
| Novartis Pharmaceuticals Corporation | 9 | $180 |
| Organon LLC | 7 | $118 |
| LEO Pharma Inc. | 5 | $88 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $78 |
Products named: OPZELURA, TREMFYA, NEMLUVIO, ILUMYA, BOTOX, Bimzelx, SKYRIZI, BLU-U.
Industry payments across AL — which companies pay providers there.
